Risk profiles for mild cognitive impairment and progression to dementia are gender specific

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 9, 2008, Pages 979-984

  Artero, S ^a,b   Ancelin, M L ^a,b   Portet, F ^a,b   Dupuy, A ^a,b   Berr, C ^a,b   Dartigues, J F ^a,c   Tzourio, C ^a,d   Rouaud, O ^a,d   Poncet, M ^e   Pasquier, F ^f,g   Auriacombe, S ^a,c   Touchon, J ^a,b   Ritchie, K ^a,b,h  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e TIMONE HOSPITAL   (France)

^f UNIV LILLE   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h Montpellier 1 University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

AGED; ALLELE; ARTICLE; BODY MASS; CLINICAL EVALUATION; COGNITIVE DEFECT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

EID: 50449106272     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.136903     Document Type: Article

References (28)

1. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-8
2. Busse A, Bischkopf J, Riedel-Heller SG, et al. Mild cognitive impairment: prevalence and predictive validity according to current approaches. Acta Neurol Scand 2003;108:71-81
3. Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment Neurology 2003;61:1179-84.
4. Lopez OL, Jagust WJ, Dulberg C, et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol 2003;60:1394-9.
5. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001;56:37-42.
6. Fischer P, Jungwirth S, Zehetmayer S, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 2007;68:288-91.
7. Manly JJ, Bell-McGinty S, Tang MX, et al. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol 2005;62:1739-46.
8. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-403.
9. Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999;45:358-68.
10. Tervo S, Kivipelto M, Hanninen T, et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 2004;17:196-203.
11. The 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 2003;22:316-25.
12. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Internal Med 2004;256:240-6.
13. Altera S, Petersen R, Touchon J, et al. Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord 2006;22:465-70.
14. Benton A. Manuel pour l'application du test de retention visuelle. Applications cliniques et experimentales. Paris: Centre de Psychologie Appliqué, 1965.
15. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage Percept Mot Skills 1965;8:271-6
16. Isaac B, kennie AT The Set test as an aid to the detection of dementia in old people. Br J Psychiatry 1973;123:467-70.
17. Dubois B, Touchon J, Portet F, et al. ("The 5 words": a simple and sensitive test for the diagnosis of Alzheimer's disease). (In French.) Presse Med 2002;31:1696-9.
18. Blair JR. Predicting premorbid IQ: a revision of the National Adult Reading Test. Clin Neuropsychol 1989;3:129-36.
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edn) (DSM-IV). Washington, DC: APA, 1994.
20. Lawton MP. Scales to measure competence in everyday activities. Psychopharmacol Bull 1988;24:609-14
21. Ancelin ML Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006;332:455-9.
22. Radloff L. The CES-D Scale: a self report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385-401.
23. Lecrubier Y, Sheehnan D, Weiller E, et al. The MINI International Neuropsychiatric Interview (MINI), a short diagnostic interview: reliability and validity according to the CIDI. European Psychiatry 1997;12:232-41.
24. Ritchie K. Mild cognitive impairment: an epidemiological perspective. Dialogues Clin Neurosci 2004;3:333-40.
25. Azad NA, Al Bugami M, Loy-English I. Gender differences in dementia risk factors. Gend Med 2007;4:120-9.
26. Knopman DS, Edland SD, Cha RH, et al. Incident dementia in women is preceded by weight loss by at least a decade. Neurology 2007;69:739-46.
27. Fleisher A, Grundman M, Jack CR Jr, et al. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol 2005;62:953-7.
28. Forsell V, Palmer K, Fratiglioni L. Psychiatric symptoms/syndromes in elderly persons with mild cognitive impairment. Data from a cross-sectional study. Acta Neurol Scand 2003;179(Suppl):25-8.